Henan Jinyuan Hydrogenated Chemicals (HKG:2502) expects a 56% decline in attributable comprehensive income in 2024 to around 24 million yuan from 55 million yuan a year prior, a Monday Hong Kong bourse filing said.
The chemical company attributed the lower anticipated income mainly to a narrower gross profit of its major product, hydrogenated benzene-based chemicals.